Media Thread, page-2120

Hi O&E,

I’m so sorry to hear that. The hardest thing to leave your children & partner behind & for the kids, and yourself, just devastating.

This is what IMU have done in Her-Vaxx - Stage 3B & the majority of patients Stage 4 gastric cancer and now in PD1-Vaxx in NSCLC that haven’t responded to prior treatment, same staging.

I think it’s important to note that we are going for the most difficult to treat end of the spectrum & how the numbers reflect when results come out. It’s not treating from the earliest stages.

It’s good the FDA are recognising this, because it’s not really ethical that those patients that most need to be on a clinical trial with promising treatment, get excluded because it might fudge their numbers up in PFS & OS.

GLTAH